ELUMIDOR Trademark

Trademark Overview

On Friday, December 16, 2016, a trademark application was filed for ELUMIDOR with the United States Patent and Trademark Office. The USPTO has given the ELUMIDOR trademark a serial number of 87271227. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Alkermes Pharma Ireland Limited. The ELUMIDOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder
elumidor

General Information

Serial Number87271227
Word MarkELUMIDOR
Filing DateFriday, December 16, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin 4
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin 4
IE

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, January 6, 2020ASSIGNED TO EXAMINER
Thursday, October 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019EXTENSION 5 GRANTED
Friday, October 4, 2019EXTENSION 5 FILED
Wednesday, October 9, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 4, 2019TEAS EXTENSION RECEIVED
Thursday, April 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2019EXTENSION 4 GRANTED
Tuesday, April 23, 2019EXTENSION 4 FILED
Tuesday, April 23, 2019TEAS EXTENSION RECEIVED
Friday, October 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 24, 2018EXTENSION 3 GRANTED
Wednesday, October 24, 2018EXTENSION 3 FILED
Wednesday, October 24, 2018TEAS EXTENSION RECEIVED
Friday, February 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2018EXTENSION 2 GRANTED
Wednesday, February 14, 2018EXTENSION 2 FILED
Wednesday, February 14, 2018TEAS EXTENSION RECEIVED
Thursday, August 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 22, 2017EXTENSION 1 GRANTED
Tuesday, August 22, 2017EXTENSION 1 FILED
Tuesday, August 22, 2017TEAS EXTENSION RECEIVED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, January 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 17, 2017NON-FINAL ACTION E-MAILED
Tuesday, January 17, 2017NON-FINAL ACTION WRITTEN
Tuesday, January 10, 2017ASSIGNED TO EXAMINER
Thursday, December 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 20, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

elumidor disorder depression depressive bipolar premenstrual treatment major disorders dysphoric affective